Human papillomavirus infection and invasive cervical cancer in Paraguay

被引:0
|
作者
Rolón, PA
Smith, JS
Muñoz, N
Klug, SJ
Herrero, R
Bosch, X
Llamosas, F
Meijer, CJLM
Walboomers, JMM
机构
[1] Int Agcy Res Canc, Unit Field & Intervent Studies, F-69372 Lyon, France
[2] Lab Anat Patol & Citol, Asuncion, Paraguay
[3] Univ Munich, Dept Med Informat Biometry & Epidemiol, Munich, Germany
[4] Inst Catala Oncol, Barcelona, Spain
[5] Free Univ Amsterdam Hosp, Amsterdam, Netherlands
关键词
D O I
10.1002/(SICI)1097-0215(20000215)85:4<486::AID-IJC7>3.0.CO;2-S
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HPV types 16 and 18 have been categorized as human carcinogens based on their strong associations with cervical cancer in previous case-control studies. Recent IARC studies in the Philippines, Thailand and Morocco show strong associations between invasive cervical cancer and less common HPV types, including HPV 31, 33, 45, 51, 52 and 58, We present results of a further IARC case-control study conducted in Asuncion, Paraguay, to examine the association between specific HPV types and invasive cervical cancer as well as risk factors other than HPV, One-hundred thirteen incident histologically confirmed invasive cervical cancer cases and 91 age-matched hospital controls were recruited. A standardized questionnaire was administered to investigate known and suspected risk factors for cervical cancer. For HPV status determination, cervical biopsy specimens from case subjects and exfoliated cervical cells from control subjects were obtained. HPV DNA was ascertained using a GP5+/6+ PCR-based assay capable of detecting more than 33 HPV types. Overall HPV prevalence was 97% in the cervical cancer cases and 20% in the control subjects. As a single infection, HPV 16 was the predominant type with a prevalence of 48% among case subjects and 5.5% among control subjects. Significant associations with the risk of cervical cancer were detected as follows: any HPV type (OR 114; 95% CI: 36-361); HPV 16 (OR = 910); HPV 18 (infinite OR); HPV 31 (OR = 110); HPV 33 (OR = 261); HPV 45 (OR = 129); and HPV 58 (OR = 36). In the multivariate model, risk factors other than HPV significantly associated with cervical cancer risk were a higher number of lifetime sexual partners, lower educational status and never having had a Pap smear. Strong associations were found between invasive cervical cancer and specific HPV types 16, 18, 31, 33, 45 and 58. Int. J. Cancer 85:486-491, 2000. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:486 / 491
页数:6
相关论文
共 50 条
  • [1] INVASIVE CERVICAL-CANCER FOLLOWING CRYOTHERAPY FOR CERVICAL INTRAEPITHELIAL NEOPLASIA OR HUMAN PAPILLOMAVIRUS INFECTION
    SCHMIDT, C
    PRETORIUS, RG
    BONIN, M
    HANSON, L
    SEMRAD, N
    WATRING, W
    [J]. OBSTETRICS AND GYNECOLOGY, 1992, 80 (05): : 797 - 800
  • [2] HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL-CANCER
    BREMOND, A
    [J]. BULLETIN DU CANCER, 1990, 77 (04) : 317 - 318
  • [3] The epidemiology of human papillomavirus infection and cervical cancer
    Bosch, F. Xavier
    de Sanjose, Silvia
    [J]. DISEASE MARKERS, 2007, 23 (04) : 213 - 227
  • [4] Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer
    Dillner, J
    Lehtinen, M
    Bjorge, T
    Luostarinen, T
    Youngman, L
    Jellum, E
    Koskela, P
    Gislefoss, RE
    Hallmans, G
    Paavonen, J
    Sapp, M
    Schiller, JT
    Hakulinen, T
    Thoresen, S
    Hakama, M
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (17) : 1293 - 1299
  • [5] Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa
    Clifford, Gary M.
    de Vuyst, Hugo
    Tenet, Vanessa
    Plummer, Martyn
    Tully, Stephen
    Franceschi, Silvia
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 73 (03) : 332 - 339
  • [6] Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: A case-control study
    Ferrera, A
    Velema, JP
    Figueroa, M
    Bulnes, R
    Toro, LA
    Claros, JM
    De Barahona, O
    Melchers, WJG
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1999, 82 (06) : 799 - 803
  • [7] Human papillomavirus genotypes in invasive cervical cancer in Jordan
    Sughayer, Maher A.
    Abdelhadi, Mohammad
    Abdeen, Ghadeer
    Otay, Lian
    Dayeh, Tasnim
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 108 (01) : 74 - 75
  • [8] HUMAN PAPILLOMAVIRUS AND INVASIVE CERVICAL-CANCER IN BRAZIL
    ELUFNETO, J
    BOOTH, M
    MUNOZ, N
    BOSCH, FX
    MEIJER, CJLM
    WALBOOMERS, JMM
    [J]. BRITISH JOURNAL OF CANCER, 1994, 69 (01) : 114 - 119
  • [9] Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana
    Tawe, Leabaneng
    MacDuffie, Emily
    Narasimhamurthy, Mohan
    Wang, Qiao
    Gaseitsiwe, Simani
    Moyo, Sikhulile
    Kasvosve, Ishmael
    Shin, Sanghyuk S.
    Zetola, Nicola M.
    Paganotti, Giacomo M.
    Grover, Surbhi
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (06) : 1667 - 1673
  • [10] Molecular tests to detect human papillomavirus infection in patients with cervical dysplasia and invasive cervical cancer in Saudi Arabia
    Sait, Khalid H.
    Gazzaz, Faten S.
    [J]. PATHOLOGY AND LABORATORY MEDICINE INTERNATIONAL, 2011, 3 : 25 - 29